Syros Pharmaceuticals (NASDAQ:SYRS) Given Buy Rating at HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report)‘s stock had its “overweight” rating reiterated by Piper Sandler in a research note issued on Wednesday, Benzinga reports. They presently have a $13.00 price objective on the stock. Piper Sandler’s price target indicates a potential upside of 166.94% from the stock’s current price. Other analysts have also recently […]
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 1,740,000 shares, an increase of 31.8% from the February 29th total of 1,320,000 shares. Approximately 9.6% of the shares of the stock are short sold. Based […]
Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday. Syros Pharmaceuticals Price Performance Shares of NASDAQ SYRS traded down $0.10 during mid-day trading on Tuesday, reaching $6.46. The company had a […]
Syros Pharmaceuticals (NASDAQ:SYRS) Lifted to Hold at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.